- Primary prevention ICD implantation in patients with left bundle branch block and nonischemic cardiomyopathy. [Letter]Rev Port Cardiol. 2026 Aug 08. [Online ahead of print]RP
- Publisher Full Text (DOI)
- Connexin 37 and cardiovascular events in a Madeiran cohort. [Journal Article]Rev Port Cardiol. 2026 Aug; 45(8):431-432.RP
- Publisher Full Text (DOI)
- When Less May Be Enough: A Pragmatic Haemodynamic Strategy for Degenerative Mitral Stenosis. [Journal Article]Rev Port Cardiol. 2026 Aug; 45(8):417-419.RP
- Publisher Full Text (DOI)
- All-cause mortality benefits of attending phase 3 cardiac rehabilitation: A systematic review. [Review]Rev Port Cardiol. 2026 Aug 05. [Online ahead of print]RP
- CONCLUSIONS: This systematic review demonstrates that attending a phase 3 CR program has the beneficial effect of reducing mortality among patients with cardiovascular disease, in particular those with coronary artery disease. These findings highlight the importance of CR participation on a long-term basis and reinforce the value of globally increasing the number of specialized centers and optimizing patient referrals to participate in a phase 3 CR long-term program.
- Publisher Full Text (DOI)
- Intensive lipid lowering therapy strategies in acute coronary syndrome patients in contemporary clinical practice - the benefit of the "strike early, strike strong" approach. [Journal Article]Rev Port Cardiol. 2026 Aug 05. [Online ahead of print]RP
- CONCLUSIONS: Low-density lipoprotein target attainment was suboptimal at median follow-up of six months. The LDL-C target group was associated with combination therapy with HI-statins plus ezetimibe upfront, better adherence and greater LDL-C reduction. These findings support the "strike early, strike strong" approach in very high-risk patients.
- Publisher Full Text (DOI)
- Impact of sodium-glucose cotransporter 2 inhibitors on blood glucose levels in heart failure with reduced ejection fraction patients without diabetes. [Journal Article]Rev Port Cardiol. 2026 Aug 05. [Online ahead of print]RP
- CONCLUSIONS: SGLT2 inhibitors safely reduce blood glucose in patients with HFrEF without diabetes without causing hypoglycemia, highlighting their potential cardiovascular and metabolic benefits and supporting their use in this population.
- Publisher Full Text (DOI)
- DysLipidemiA iN primary care paTiEnts - tReatment and coNtrol (Estudo LANTERN) Algarve. [Journal Article]Rev Port Cardiol. 2026 Aug 05. [Online ahead of print]RP
- CONCLUSIONS: LDL-C target achievement remains suboptimal in Portuguese primary care, particularly in high-risk patients. Underuse of intensive treatment highlights opportunities for improving CV prevention, especially through updated risk assessment tools like SCORE2/OP.
- Publisher Full Text (DOI)
- Re: Left bundle branch area pacing in LBBB-induced cardiomyopathy: Is the defibrillator component necessary? [Letter]Rev Port Cardiol. 2026 Jul 23. [Online ahead of print]RP
- Publisher Full Text (DOI)
- Trends in infective endocarditis microbiology and valve replacement at a hospital center. [Letter]Rev Port Cardiol. 2026 Jul 20. [Online ahead of print]RP
- Publisher Full Text (DOI)
- Ramping UBIquitinomics for the design of new sex-specific therapeutic strategies for aortic valve stenosis: study protocol. [Journal Article]Rev Port Cardiol. 2026 Jul 20. [Online ahead of print]RP
- CONCLUSIONS: RUBITAV is expected to advance our understanding of the role of protein ubiquitination in AVS, identify new sex-specific therapeutic targets, and pave the way for the application of PROTACs in the treatment of AVS.
- Publisher Full Text (DOI)
- A cardiomyopathy puzzle: What is relevant and what is incidental? [Journal Article]Rev Port Cardiol. 2026 Jul 18. [Online ahead of print]RP
- Publisher Full Text (DOI)
- Dual left anterior descending artery type IV: The role of coronary computed tomography angiography - anatomical classification and risk. [Journal Article]Rev Port Cardiol. 2026 Jul 18. [Online ahead of print]RP
- Publisher Full Text (DOI)
- Cooperating to care: cardiology between Portugal and Mozambique. [Journal Article]Rev Port Cardiol. 2026 Aug 01. [Online ahead of print]RP
- Publisher Full Text (DOI)
- Prognosis of acute myocarditis beyond hospitalization: Results of a long-term prospective study. [Journal Article]Rev Port Cardiol. 2026 Jul 03. [Online ahead of print]RP
- CONCLUSIONS: AM in adults typically followed a benign course with favorable short- and long-term outcomes. In contrast, a small but significant subset with FM had a markedly poorer prognosis, with severe recurrences frequently proving fatal. Clinical presentation was the sole determinant of prognosis, prompting consideration of whether patients with milder cases truly require extended FUP.
- Publisher Full Text (DOI)
- Exploring the impact of the GJA4 rs618675 variant on cardiovascular prevention. [Journal Article]Rev Port Cardiol. 2026 Aug; 45(8):421-429.RP
- CONCLUSIONS: We have demonstrated that the CC variant of GJA4 is significantly associated with CV events. Further investigations into this biomarker may improve CV risk prediction, leading to better primary prevention.
- Publisher Full Text (DOI)